Nanologica operates in the field of nanotechnology. Currently the main business focus is on the sectors Drug Delivery and Chromatography, which includes the development of pharmaceutical administration and technology used for the separation and purification of products. The research is carried out in collaboration with Stockholm University and the Ångström Laboratory at Uppsala University. The company was founded in 2004 and is based in Södertälje.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Flerie Invest AB | 27,91 | 27,91 | 2024-11-18 |
| Kungliga Konstakademien | 4,82 | 4,82 | 2024-09-26 |
| Andreas Bhagwani | 4,57 | 4,57 | 2024-09-26 |
| Avanza Pension | 4,23 | 4,23 | 2024-09-26 |
| Swedbank Robur Fonder | 3,05 | 3,05 | 2024-10-31 |
| Redeye | 2,51 | 2,51 | 2024-11-30 |
| Andre Oscar och Anna Wallenbergs stiftelse | 2,08 | 2,08 | 2024-09-26 |
| CJ Invest | 2,00 | 2,00 | 2024-09-26 |
| Fredrik Palmstierna | 1,68 | 1,68 | 2024-09-26 |
| QQM Fund Management AB | 1,59 | 1,59 | 2024-11-30 |
